Skip to main content

Advertisement

SpringerLink
Log in

Apoptosis induced in human colorectal carcinoma by anti-fas antibody

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Apoptosis or programmed cell death has been shown to play an important role in the progression from polyps to carcinomas. Fas/APO-1 is a cell surface protein that can induce apoptosis in a variety of cell types upon specific antibody binding. In this study seven human colorectal carcinoma (HCRC) cell lines of varying differentiation were analyzed for cell surface Fas expression, Fas-mediated apoptosis, and correlation of apoptosis withbcl-2 expression.

Methods and Results: Using flow cytometry, all seven lines expressed varying amounts of cell surface Fas antigen. Exposure to anti-Fas antibody induced cell death in all the cell lines, albeit to varying degrees. The rate of apoptosis was quantitated using flow cytometry with propidium iodide staining of nuclear DNA. The poorly differentiated cell lines had a significantly decreased (p<0.05) anti-Fas sensitivity as compared with the well-differentiated lines. Measurement ofbcl-2 expression by flow cytometry showed an inverse correlation with anti-Fas sensitivity.

Conclusions: This study confirms that HCRC cell lines express Fas antigen and, more importantly, provides the first evidence that exposure to anti-Fas antibody can induce apoptosis. Fas-mediated apoptosis in HCRC cell lines may be regulated bybcl-2 and may correlate with the degree of differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics.Br J Cancer 1972;26:239–57.

    CAS  PubMed  Google Scholar 

  2. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy.Cancer 1994;73:2013–26.

    CAS  PubMed  Google Scholar 

  3. Lowe S, Ruley HF, Jacks T, et al. p53 dependent apoptosis modulates the cytotoxicity of anti-cancer agents.Cell 1993;74:957–67.

    Article  CAS  PubMed  Google Scholar 

  4. Shaw P, Bovey R, Tardy S, et al. Induction of apoptosis by wild-type p53 in a human colon tumor derived cell line.Proc Natl Acad Sci U S A 1992;89:4495–9.

    CAS  PubMed  Google Scholar 

  5. Reed JC.bcl-2 and the regulation of programmed cell death.J Cell Biol 1994;124:2–6.

    Article  Google Scholar 

  6. Rasbridge SA, Gillett CE, Seymour AM, et al. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma.Br J Cancer 1994;70:335–41.

    CAS  PubMed  Google Scholar 

  7. Bursch W, Liehr JG, Sirbasku DA, et al. Control of cell death (apoptosis) by diethylstilbestrol in an estrogen dependent kidney tumor.Carcinogenesis 1993;12:855–60.

    Google Scholar 

  8. Garczyca W, Gary J, Ardelt B, et al. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various anti-tumor agents.Cancer Res 1993;53:3186–92.

    Google Scholar 

  9. Staunton M, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis.Am J Clin Pathol 1995;103:300–7.

    CAS  PubMed  Google Scholar 

  10. Aihara M, Scardino PT, Truong LD, et al. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate.Cancer 1995;75:522–9.

    CAS  PubMed  Google Scholar 

  11. Mooney EE, Peris JMR, O'Neill A, et al. Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma.J Clin Pathol 1995;48:242–4.

    CAS  PubMed  Google Scholar 

  12. Kasagi N, Gamyo Y, Shirai H, et al. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling.Jpn J Cancer Res 1994;85:939–45.

    CAS  PubMed  Google Scholar 

  13. Sen S, D'Incalci M. Apoptosis: biochemical events and relevance to cancer chemotherapy.Fed Eur Biochem Soc 1992;307:122–7.

    CAS  Google Scholar 

  14. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.Cell 1991;66:233–43.

    Article  CAS  PubMed  Google Scholar 

  15. Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.Cell 1993;75:1169–78.

    Article  CAS  PubMed  Google Scholar 

  16. Owen-Schaub L, Meterissian S, Ford RJ. Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin.J Immunother 1993;14:234–41.

    CAS  PubMed  Google Scholar 

  17. Moller P, Koretz K, Leithauser F, et al. Expression of APO-1 (CD95) a member of the NGF/TNF receptor superfamily in normal and neoplastic colon epithelium.Int J Cancer 1994;57:371–7.

    CAS  PubMed  Google Scholar 

  18. Meterissian SH, Toth CA, Steele G, et al. Kupffer cell/tumor cell interactions and hepatic metastases in colorectal cancer.Cancer Lett 1994;81:5–12.

    Article  CAS  PubMed  Google Scholar 

  19. Aiello A, Delia D, Barrello MG, et al. Flow cytometic detection of the mitochondrialbcl-2 protein in normal and neoplastic human lymphoid cells.Cytometry 1992;13:502–9.

    Article  CAS  PubMed  Google Scholar 

  20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J Immunol Meth 1983;65:55–63.

    Article  CAS  Google Scholar 

  21. Crompton T. IL-3 dependent cells die by apoptosis on removal of their growth factor.Growth Factors 1991;4:109–16.

    CAS  PubMed  Google Scholar 

  22. Shi Y, Szalay MG, Paskar L, et al. Activation induced cell death in T cell hybridomas is due to apoptosis.J Immunol 1990;144:3326–33.

    CAS  PubMed  Google Scholar 

  23. Sellins KS, Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes.J Immunol 1987;139:199–206.

    Google Scholar 

  24. Martin SJ, Lenman SV, Bonham AM, et al. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis.J Immunol 1990;145:859–67.

    Google Scholar 

  25. Collins RJ, Harmon BV, Sowles T, et al. Effects of cycloheximide on B-chronic lymphocytic leukemic and normal lymphocytes in vitro: induction of apoptosis.Br J Cancer 1991;64:518–22.

    CAS  PubMed  Google Scholar 

  26. Cohen JJ. Programmed cell death in the immune system.Adv Immunol 1991;50:55–85.

    CAS  PubMed  Google Scholar 

  27. Owens GP, Cohen JJ. Identification of genes involved in programmed cell death.Cancer Metastasis Rev 1992;11:149–56.

    CAS  PubMed  Google Scholar 

  28. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis.Nature 1995;375:78–81.

    Article  CAS  PubMed  Google Scholar 

  29. Los M, Craen MV, Penning LC, et al. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis.Nature 1995;375:81–3.

    Article  CAS  PubMed  Google Scholar 

  30. Itoh N, Nagata S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen.J Biol Chem 1993;268:10932–7.

    CAS  PubMed  Google Scholar 

  31. Watanabe-Fukunuga R, Brannon C, Copeland N, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.Nature 1992;756:314–7.

    Google Scholar 

  32. Mapara MY, Bargou R, Zuyck C, et al. APO-1 mediated apoptosis or proliferation in human chronic B-lymphocytic leukemia: correlation withbcl-2 oncogene expression.Eur J Immunol 1993;23:702–8.

    CAS  PubMed  Google Scholar 

  33. Itoh N, Tsujimoto Y, Nagata S. Effect ofbcl-2 on Fas antigen mediated cell death.J Immunol 1993;263:1759–62.

    Google Scholar 

  34. Cheng J, Zhan T Liu C, Shapiro J, et al. Protection from Fasmediated apoptosis by a soluble form of the Fas molecule.Science 1994;263:1759–62.

    CAS  PubMed  Google Scholar 

  35. Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of APO-1, a new member of the NGF/TNF receptor superfamily in normal and neoplastic cells.Lab Invest 1993;69:415–29.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada

    Sarkis H. Meterissian MD, Maria Kontogiannea BSc, John Po BSc, Gitte Jensen PhD & Brett Ferdinand MD

Authors
  1. Sarkis H. Meterissian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Kontogiannea BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Po BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gitte Jensen PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brett Ferdinand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meterissian, S.H., Kontogiannea, M., Po, J. et al. Apoptosis induced in human colorectal carcinoma by anti-fas antibody. Annals of Surgical Oncology 4, 169–175 (1997). https://doi.org/10.1007/BF02303801

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303801

Key Words

Search

Navigation